| [1] |
Gandaglia G, Briganti A, Gontero P, et al. The role of chronic prostatic inflammation in the pathogenesis and progression of benign prostatic[J]. BJU Int, 2013, 112(4):432-441.
|
| [2] |
黄向华，覃斌，梁毅文，等. 合并组织学前列腺炎的良性前列腺增重患者TURP手术对下尿路症状的影响[J]. 中华男科学杂志, 2013, 19(1): 35-39.
|
| [3] |
Qian X, Kong X, Qian Y, et al. Therapeutic efficacy of Cernilton in benign prostatic hyperplasia patients with histological prostatitis after transurethral resection of the prostate[J]. Int J Clin Exp Med, 2015, 8(7): 11268-11275.
|
| [4] |
张峰，阿斯木江·阿不拉，张立东. 组织学前列腺炎对良性前列腺增生、前列腺癌患者临床特点的影响[J]. 中华男科学杂志, 2014, 20(4): 354-358.
|
| [5] |
Gandaglia G, Briganti A, Gontero P, et al. The role of chronic prostatic inflammation in the pathogenesis and progression of benign prostatic hyperplasia (BPH)[J]. BJU Int, 2013, 112(4): 432-41.
|
| [6] |
阮黎，华兴，李刚，等. 组织学前列腺炎对经尿道前列腺剜除术的影响和临床意义[J/CD]. 中华腔镜泌尿外科杂志（电子版）, 2014, 8(2): 81-84.
|
| [7] |
虞永江，夏佳，钱苏波，等. 慢性前列腺炎患者前列腺电切术后下尿路症状及膀胱颈挛缩发生的临床研究[J]. 中国男科学杂志, 2017, 31(5): 12-14,19.
|
| [8] |
Doluoglu OG, Gokkaya CS, Aktas BK, et al. Impact of asymptomatic prostatitis on re-operations due to urethral stricture or bladder neck contracture developed after TURP[J]. Int Urol Nephrol, 2012, 44(4): 1085-1090.
|
| [9] |
李锋. 选择性α1受体阻滞剂在经尿道前列腺汽化电切术后早期的应用价值[J]. 中华老年医学杂志, 2013, 32(2): 178-179.
|
| [10] |
Wang H, Zhang L, Jiang N A, et al. Anti-inflammatory effects of escin are correlated with the glucocorticoid receptor/NF-κB signaling pathway, but not the COX/PGF2α signaling pathway[J]. Exp Ther Med, 2013, 6(2): 419-422.
|
| [11] |
Ficarra V, Rossanese M, Zazzara M, et al. The role of inflammation in lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) and its potential impact on medical therapy[J]. Curr Urol Rep, 2014, 15(12): 463.
|
| [12] |
Qian X, Kong X, Qian Y, et al. Therapeutic efficacy of Cernilton in benign prostatic hyperplasia patients with histological prostatitis after transurethral resection of the prostate[J]. Int J Clin Exp Med, 2015, 8(7): 11268-112675.
|
| [13] |
Domanski D, Zegrocka-Stendel O, Perzanowska A, et al. Molecular Mechanism for Cellular Response to β-Escin and Its Therapeutic Implications[J]. PLoS One, 2016, 11(10): e0164365.
|
| [14] |
Zhang F, Man X, Yu H, et al. Synergistic protective effects of escin and low dose glucocorticoids against vascular endothelial growth factor induced blood retinal barrier breakdown in retinal pigment epithelial and umbilical vein endothelial cells[J]. Mol Med Rep，2015, 11(2): 1372-1377.
|
| [15] |
Wada N, Watanabe M, Kita M, et al. Analysis of bladder vascular resistance before and after prostatic surgery in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction[J]. Neurourol Urodyn, 2012, 31(5): 659-663.
|
| [16] |
Li M, Lu C, Zhang L, et al. Oral administration of escin inhibits acute inflammation and reduces intestinal mucosal injury in animal models[J]. Evid Based Complement Alternat Med, 2015(2): 503617.
|